Terry To Leave As DRCCA Acting Director Sept. 1, Peter Greenwald Is DeVita’s Choice For The Job
In Brief: AMOS Says Cancer Program Should Not Have Ceiling Of $1 Billion; OSHA Drops Effort To Fire Infants
FDA Commissioner Holds Up IND While Reviewing Toxicology Guidelines
FCRC Preproposal Conference Draws 36 Institutions
Nutrition Research Tests Hypotheses, Seeks Explanation Of Differences
Consensus Growing On Prevention Strategies: Higginson
Trending Stories
- Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives - The Directors: Two Gulf Coast cancer center directors on why NCI designation matters—and why they want it
Lucio Miele and Raghu Kalluri: Science and technology have changed what an aspiring cancer center must accomplish - From “default dead” to living the future of cancer care
As founding CEO of GitLab, I went “founder mode” on my osteosarcoma - Brian Wolpin celebrates FDA approval of daraxonrasib in pancreatic cancer as the future of the field
- FDA advisory committee votes in favor of Galleri approval, but calls for removal of “early” detection claims
Clinical benefit will not be considered for approval, FDA says - Trump weighs—and abandons—an executive order that would give OMB veto power over NIH grants
